OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy as a possible trigger for the myocardial lipomatosis development
Ashot Avagimyan, Lusine Mkrtchyan, Н. Б. Конончук, et al.
Arterial’naya Gipertenziya (Arterial Hypertension) (2022) Vol. 27, Iss. 6, pp. 706-712
Open Access | Times Cited: 10

Showing 10 citing articles:

Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine
Ashot Avagimyan, Nana Pogosova, Federica Fogacci, et al.
International Journal of Cardiology (2024) Vol. 418, pp. 132663-132663
Closed Access | Times Cited: 16

DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 13

Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy
Ashot Avagimyan, Mohammad Sheibani, Nana Pogosova, et al.
International Journal of Cardiology (2023) Vol. 391, pp. 131331-131331
Closed Access | Times Cited: 13

Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani, et al.
Innovative medicine of Kuban (2023), Iss. 4, pp. 6-14
Open Access | Times Cited: 3

Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts
Ashot Avagimyan, Federica Fogacci, Nana Pogosova, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102230-102230
Closed Access | Times Cited: 2

Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia
Ashot Avagimyan, L. V. Kakturskiy
Siberian Journal of Clinical and Experimental Medicine (2022) Vol. 37, Iss. 2, pp. 105-111
Open Access | Times Cited: 4

Trimetazidine as a Modifier of Chemotherapy-Induced Endothelium Homeostasis Disturbances
А.А. Авагимян, Л.В. Кактурский
Кардиология в Беларуси (2022), Iss. 3, pp. 263-272
Open Access | Times Cited: 4

CARDIOTOXICITY OF CYCLOPHOSPHAMIDE: CURRENT STATE OF THE PROBLEM
Ashot Avagimyan, L. V. Kaktursky
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA (2022)
Open Access | Times Cited: 3

Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
Ashot Avagimyan
Сибирский научный медицинский журнал (2022) Vol. 42, Iss. 3, pp. 41-46
Open Access | Times Cited: 2

Antineoplastics

Reactions Weekly (2022) Vol. 1936, Iss. 1, pp. 75-75
Closed Access

Page 1

Scroll to top